Legal
Cut Ring-Fence Rules: UK Treasury Frees £80B
UK Treasury plans to ease ringfencing rules, freeing £80 billion in lending capacity for banks that argued the post-2008 rules cost too much.
Latest — Page 2
Legal
CISA Contractor Leaked GovCloud Keys on GitHub
A CISA contractor disabled GitHub's secret scanning before publishing AWS GovCloud admin keys and plaintext passwords to a public repository.
Legal
Stole 1.8M Fingerprints in NYC Hospital Breach
NYC's largest public health system had fingerprints and palm prints stolen, covering 1.8M people, with no explanation for why it stored biometrics.
Legal
Judge Fines Cliq $6.5M Over 2015 FTC Order
Federal judge fines Cliq $6.5M for violating its 2015 FTC consent order, far below the $52.9M sought, but no receiver and no industry ban.
AI
Summoned by G20, Anthropic Briefs on Mythos Risks
Anthropic will brief the G20's FSB on Mythos, which found thousands of high-severity vulnerabilities leaving many regulators on the outside.
FDA
FDA Cleared Lilly Foundayo in $9.3B Obesity Race
Lilly cleared Foundayo on April 1, but the label carries a required post-market trial for four serious risks, including MACE and liver injury.
FDA
FDA Clears AstraZeneca's Baxfendy, $5B Peak Sales
AstraZeneca's $1.3B CinCor buy paid off: FDA cleared Baxfendy, first-in-class for hypertension, with Leerink's $10B upside scenario on the table.
Deals
Regeneron Commits $125M Upfront in $2.3B Parabilis Deal
Regeneron pays $125M upfront in a $2.3B Parabilis collaboration to build antibody-helicon conjugates, a drug class that doesn't exist yet.
FDA
FDA Alleges Fraud as Tavneos Deaths Hit 20 in Japan
A $3.7 billion drug acquisition is unraveling: 20 deaths, a market withdrawal demand, and now FDA allegations of manipulated trial data.
Deals
Boston Scientific buys into MiRus for up to $4.5B
Boston Scientific paid $1.5B for 34% of MiRus and locked in a $3B option for its SIEGEL TAVR system, one year after scrapping its own valve program.
FDA
FDA cleared Enhertu twice: early breast cancer, $5.4B
Enhertu's $5.4B annual sales projection grows with dual early breast cancer clearance, but patients who used it before surgery can't get it after.
FDA
Paid $270M for BMN 401, BioMarin Misses Phase 3
BioMarin's $270M Inozyme bet just got complicated: BMN 401 hit the biomarker endpoint but missed skeletal healing and all secondary goals.
Legal
Sued: Adani Executives Over $750M Bond Fraud
Adani Green sold $750M in bonds while its founder personally orchestrated bribe payments to Indian officials, the SEC alleged in late 2024.
SEC
CFPB Drops Disparate Impact in 3-Part ECOA Overhaul
CFPB just scrapped disparate impact under ECOA, but mortgage lenders and state AGs in New York, New Jersey, and Massachusetts won't play along.
Legal
Polis Cuts Peters' 9-Year Election Data Sentence
Judge Barrett called Peters a 'charlatan' who'd do it again. Colorado's governor cut her 9-year sentence anyway, after just 18 months.
